Do you know anything about genetic analysis? If no then let me tell you that it enables personalizing of pharma treatments of patients suffering from cancer and hence enhances the therapeutic effect and minimizes the possible toxicity as a result. University Hospital researchers along with Pharmacogenomics laboratory took the analyses predictive of responses to pharama drugs in patients suffering from lung cancer and sarcoma.
Researches in the case of gene mutation of EGFR can help in determining the response of the tyrosine quinase inhibitors of the epidermic growth factor receptor. As of now the researchers are analyzing the genetic changes which can help in defining then parameters required for interpreting the best set of pharma drugs which could be effective on certain tumors. This can not only help in identification of treatments but also help in keeping a tab on the toxicity profile occurring with the aid of medicinal drugs.
Via spiritindia
